Skip to main content

Molecular survey of mcr1 and mcr2 plasmid mediated colistin resistance genes in Escherichia coli isolates of animal origin in Iran



The emergence of colistin-resistant Enterobacteriaceae from human and animal sources is one of the major public health concerns as colistin is the last-resort antibiotic for treating infections caused by multidrug-resistant Gram-negative bacteria. We aimed to determine the prevalence of the prototype widespread colistin resistance genes (mcr-1 and mcr-2) among commensal and pathogenic Escherichia coli strains isolated from food-producing and companion animals in Iran.


A total of 607 E. coli isolates which were previously collected from different animal sources between 2008 and 2016 used to uncover the possible presence of plasmid-mediated colistin resistance genes (mcr-1 and mcr-2) by PCR. Overall, our results could not confirm the presence of any mcr-1 or mcr-2 positive E. coli among the studied isolates. It is concluded that despite the important role of food-producing animals in transferring the antibiotic resistance, they were not the main source for carriage of mcr-1 and mcr-2 in Iran until 2016. This study suggests that the other mcr variants (mcr-3 to mcr-9) might be responsible for conferring colistin resistance in animal isolates in Iran. The possible linkage between pig farming industry and high level of mcr carriage in some countries needs to be clarified in future prospective studies.


Since the advent of antimicrobial agents for clinical practices, researchers have been faced with the emergence and spread of resistant bacteria. Mechanisms of resistance are known to favor microbial growth even in high concentration of therapeutics, causing treatment failures. This phenomenon is continuously being explored in both human and veterinary medicine. The agricultural use of antibiotics is increasing, either as growth promoters or as therapeutic agents in farm animals [1]. This could be potentially a threat to human health because resistant organisms developed in food-producing animals may confer resistance to human commensal or pathogenic strains through the food chain or direct contacts [1, 2].

Colistin is an antibiotic belonging to the polymyxins family. This drug is among the top most critically important antimicrobial agents in veterinary medicine and is active against a broad range of Gram-negative bacteria including most members of the Entrobacteriaceae family [3]. Colistin targets the polyanionic lipid A of lipopolysaccharides in the outer membrane of Gram-negative bacteria [4]. This antibiotic is widely used in poultry farms for the prevention and treatment of Enterobacteriaceae infections and is the last-resort antibiotic for treating multidrug-resistant (MDR) infections [5]. Microbial resistance to colistin occurs mostly among isolates from food animals compared to the human isolates [6,7,8,9,10]. This is due to the continuous use of colistin in veterinary medicine which has led to the higher rates of colistin resistance among isolates from food animals [8]. Moreover, the emergence of extensive drug-resistant (XDR) Gram-negative bacteria (GNB) has further increased the interest of most scientists to use colistin for the treatment of severe infections caused by these pathogens [11]. Most polymyxin resistance mechanisms are chromosomally mediated and involve modulation of a two-component regulatory system (e.g., pmrAB, phoPQ, and the negative regulator mgrB), leading to modification of lipid A with moieties including phosphoethanolamine, 4-amino-4-deoxy-l-arabinose, or, in rare instances, the total loss of lipopolysaccharides [7, 12]. Recently, it was discovered that the mcr-1 (mobile-colistin-resistance) gene is associated with colistin resistance. This gene codes for enzymes capable of modifying the LPS through the addition of phosphoethanolamine [7]. The emergence of the mcr-1 gene could be a potential threat to the efficacy of polymixins and is a global concern. This gene has been detected in various Enterobacteriaceae species from the environment, food, humans, livestock, wildlife, companion animals, rivers, and vegetables in more than 50 countries and regions [13, 14]. Reports have shown evidence of eight other plasmid-mediated colistin resistance genes which include mcr-2 to mcr-9 [15]. Although colistin has been frequently used in veterinary medicine particularly in poultry in Iran, the prevalence of colistin resistance and the carriage of mcr genes among the commensal enteric bacterial isolates from food-producing animals is poorly understood. This study was conducted to survey the frequency of the prototype widespread colistin resistance genes (mcr-1 and mcr-2) among commensal and some pathogenic enteric bacteria (E. coli) isolated from animals in Iran.

Main text

Material and methods

A total of 607 E. coli isolates were collected from different animal sources including broilers, ostriches, cattle, and sheep, pigeons and dogs. These bacteria were isolated from various regions of Iran from 2008 to 2016 in the context of different previous studies. The number of samples from each animal species and geographical regions are presented in Table 1. Briefly, the original sampling procedure included collecting fecal samples using sterile cotton swabs from the rectum of cattle, sheep and dogs, and fresh droppings of pigeons and ostriches. For the extraintestinal pathogenic E. coli strains, the samples were aseptically taken from bovine mastitis milk and liver or heart blood of commercial broilers recently died of colibacillosis. The Shiga-toxin producing E. coli (STEC) strains were confirmed by different molecular methods described previously [16]. All animals were belonging to commercial production systems except dogs and pigeons. In these cases, samples were only obtained upon the owners’ consent and approval. The samples were streaked on MacConkey agar (Merck, Germany) and a pure isolate from each sample was confirmed as E. coli using standard biochemical tests [17]. All isolates were cryopreserved in Brain Heart Infusion broth (Merck, Germany) with 30% glycerol as stocks and kept at − 70 °C. The archived strains were recovered on Brain Heart Infusion broth (BHI; Merck, Germany) after overnight culture at 37 °C with an additional streak on MacConkey agar to confirm the purity of the stocks, and a single pure colony was assessed by molecular methods; when necessary, the identity of the isolates was reassessed using sets of standard biochemical tests as described in laboratory manuals. The tests included using differential media such as Triple Sugar Iron agar, Urea agar, SIM, Citrate, and MR-VP (Merck, Germany) [17]. E. coli carrying mcr-1 (2012-60-1176-27) and E. coli containing mcr-2 (KP37) were used as reference strains and positive controls in PCR reactions. All strains were tested by two sets of conventional PCR assays targeting the mcr-1 and mcr-2 resistance genes. DNA templates were extracted by boiling method as described previously [18]. Briefly, a loopful from an overnight culture on Luria Bertani agar (Merck, Germany) was suspended in 350 μl molecular grade water. Then, the suspension was boiled for 10 min and after cooling on ice, centrifuged for 5 min at 10,000×g and the supernatants were used as templates. For PCR reactions, a ready-to-use Red PCR Master Mix (Ampliqon, Denmark) containing 1.5 mM MgCl2, 0.2 mM dNTP and 0.1% Tween 20 was used. The final concentration for each primer was 0.3 μM, and 3 μl of crude DNA was used as template. The primers were (5′-CGGTCAGTCCGTTTGTTC -3′/5′-CTTGGTCGGTCTGTAGGG-3′) for mcr-1, and (5′-TGTTGCTTGTGCCGATTGGA -3′/5′-AGATGGTATTGTTGGTTGCTG-3′) for mcr-2 as described before [7, 19]. Thermal cycling conditions were conducted in TC-3000 cycler (Techne, UK) under the following conditions: for the mcr-1 amplification, one cycle of denaturation at 94 °C for 5 min, followed by 30 cycles of denaturation at 94 °C for 30 s, annealing at 58 °C for 90 s and elongation at 72 °C for 60 s, and a final cycle of elongation at 72 °C for 7 min was applied. The amplification of mcr-2 included 33 cycles of 95, 65 and 72 °C, all for 60 s. The amplification output was visualized by electrophoresis on 1.5% agarose gel at 100 V followed by staining in DNA safe stain (Cinnagen, Iran).

Table 1 The origin and characteristics of the 607 studied E. coli isolates

Results and discussion

In the present survey, no mcr-1/mcr-2 harboring E. coli were found among the 607 tested isolates of animal origin which belonged to ten provinces in Iran. Antibiotic consumption or administration in animals is known as a major contributor to the development of antimicrobial resistance in humans. The recent emergence of clinically important bacteria such as mcr-positive colistin-resistant E. coli in humans has been mostly associated with food-producing animals [20]. Globally, colistin is among the widely used antibiotics in veterinary clinical practices. The mcr genes associated with colistin resistance in Enterobacteriaceae are widespread and have been reported in veal, swine, and poultry in different countries [7, 21,22,23]. The aforesaid resistance has already become established in livestock, posing a potential threat to consumers through eating contaminated meat and other products [24].

Generally, few studies have investigated colistin resistance by molecular methods in E. coli isolates from animals in Iran. Based on the CLSI guidelines, the disc diffusion method cannot reflect resistance to colistin or harboring mobile genetic mcr elements, suggesting that some of the previous colistin susceptibility studies in Iran could be misleading. In this study, a PCR-based detection method was performed to survey the mcr-1 and mcr-2 presence among an extensive collection of E. coli strains, and none of the tested isolates carried the targeted genes. As mentioned, these strains were recovered from 2008 to 2016 from different animal sources. In a similar study, no colistin-resistant E. coli isolate was detected in poultry in the northwest of Iran [25]. Another study from southwest Iran reported 1.2% of E. coli and 0.4% of K. pneumoniae isolates from human samples carried mcr-1 gene while mcr-2 was not detected [26]. Consistently, in a recent study, no mcr-1 and mcr-2 genes were identified from Enterobacteriaceae isolates of human origin in the northwest of Iran [27]. Despite the regular administration of colistin in farm animals, the absence of mcr-1 and mcr-2 genes suggested that these genes were not widespread among animal sources in Iran at least until few years ago. Additionally, these findings partially support the low prevalence of mcr genes in human and veterinary clinical isolates in previous studies conducted in Iran.

The mcr-1, as a prototype of the plasmid resistance gene for colistin, was initially reported in E. coli from livestock, food, and humans in China in 2015 [28]. A study in China described a low prevalence of colistin-resistance E. coli among cattle (0.9%); while in comparison, such resistance among E. coli isolated from chickens and pigs was high (14% among chickens and 24% among pigs) [10]. The gene was also reported from Denmark and other countries confirming worldwide dissemination of the gene from various sources [23, 29]. A low prevalence of mcr-1 (1%) was detected in Salmonella from poultry meat (K. Veldman et al., unpublished data), E. coli isolates from livestock (1%) and meat (2%) in the Netherlands [29]. In Germany, a recent study investigating a total of 580 E. coli isolates from chicken meat, indicated a decreasing prevalence of mcr-1, from 8.1% in 2011 to 0.5% in 2014 based on isolate screening [30]. At much lower rates, the presence of mcr-1 was confirmed in isolates from poultry and other meat products from Europe in other studies [29]. The mcr-1-harboring E. coli isolates (19.5%) in chicken meat was also reported from South America based on a selective culture approach [31]. Similar reports demonstrated the presence of mcr-1 in an E. coli isolate from a cow displaying subclinical mastitis, suggesting that mcr associated resistance also emerged in Egypt despite showing a very low prevalence in this country [32]. After reporting the first mcr-1, the mcr-2 plasmid-mediated colistin resistance was subsequently described in E. coli from cattle and pigs in Belgium [19]. In China, the prevalence of mcr-2 in colistin-resistant E. coli isolates from pigs, chickens and cattle was 46.82%, 14.90%, and 19.05%, respectively, compared to the higher prevalence of mcr-1 in these species [33]. Other studies reported no mcr-2 in E. coli isolates from cattle, swine, and broilers, while the prevalence of mcr-1 slightly increased [9, 34]. Additionally, the mcr-2 was not detected in any poultry isolates in Romania [35].

It seems that the pig industry may play an important role in colistin resistance emergence and spread. In Portugal, 98% of pigs tested positive for mcr-1 harboring Enterobacteriaceae isolates (mainly E. coli), while no mcr-2 carrying isolate was identified [36]. Accordingly, a recent study on the prevalence of colistin-resistant bacteria in Ecuador showed that 41.9% of E. coli isolates from chicken and pigs harbored mcr-1 [37]. Another study in Spain revealed that the prevalence of colistin-resistant E. coli was 76.9% in pigs [15]. Also, a high prevalence of E. coli harboring mcr genes in pigs was detected in China (mcr-1 = 79.2%, mcr-2 = 56.3%) [38]. Other studies described the occurrence of mcr-1 in swine; for example, the prevalence in Europe ranged from 0.5 to 13.5% [36]. Therefore, based on the available literature, pigs have been an important reservoir of colistin plasmid-mediated resistance, and the absence of swine industrial farming in Iran or other countries like Egypt could be a possible reason for the low prevalence of mcr-1 and mcr-2 genes in food animals. It should be noted that many novel mcr variants need to be targeted in future studies in Iran to obtain a more integrated view on colistin resistance. Also, the presence of possible new mcr variants in Iran should be considered.

In conclusion, the results of this study indicated that despite the important role of animals in transferring antimicrobial resistance, we need to have a more integrated perspective about this global issue [39,40,41]. Additionally, in order to reduce the probability of transmitting resistant bacteria from animals to humans, the monitoring and antibiotic stewardship strategies should be improved.


As we described in Table 1, the studied samples in this survey originated from ten provinces in Iran, but we still need to carry out more sophisticated comprehensive studies to confirm the absence of mcr-1 and mcr-2 colistin resistance in the animal population.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.





Extensive drug-resistant


Gram-negative bacteria


Brain heart infusion agar


Whole genome sequencing


  1. 1.

    Founou LL, Founou RC, Essack SY. Antibiotic resistance in the food chain: adeveloping country-perspective. Front Microbiol. 2016.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Chang Q, Wang W, Regev-Yochay G, Lipsitch M, Hanage WP. Antibiotics in agriculture and the risk to human health: How worried should we be? Evol Appl. 2015.

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Poirel L, Jayol A, Nordmanna P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Kempf I, Jouy E, Chauvin C. Colistin use and colistin resistance in bacteria from animals. Int J Antimicrob Agents. 2016.

    Article  PubMed  Google Scholar 

  6. 6.

    Manageiro V, Clemente L, Graça R, et al. New insights into resistance to colistin and third-generation cephalosporins of Escherichia coli in poultry, Portugal: Novel blaCTX-M-166 and blaESAC genes. Int J Food Microbiol. 2017.

    Article  PubMed  Google Scholar 

  7. 7.

    Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism mcr-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016.

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    García V, García-Meniño I, Mora A, et al. Co-occurrence of mcr-1, mcr-4 and mcr-5 genes in multidrug-resistant ST10 Enterotoxigenic and Shiga toxin-producing Escherichia coli in Spain (2006–2017). Int J Antimicrob Agents. 2018.

    Article  PubMed  Google Scholar 

  9. 9.

    Kawanishi M, Abo H, Ozawa M, et al. Prevalence of colistin resistance gene mcr-1 and absence of mcr-2 in Escherichia coli isolated from healthy food-producing animals in Japan. Antimicrob Agents Chemother. 2017.

    Article  PubMed  Google Scholar 

  10. 10.

    Huang X, Yu L, Chen X, et al. High prevalence of colistin resistance and mcr-1 gene in Escherichia coli isolated from food animals in China. Front Microbiol. 2017.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11

    Conly J, Johnston B. Colistin: the phoenix arises. Can J Infect Dis Med Microbiol. 2006;17(5):267–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006.

    Article  PubMed  Google Scholar 

  13. 13.

    Feng Y. Transferability of mcr-1/2Polymyxin resistance: complex dissemination and genetic mechanism. ACS Infect Dis. 2018.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Bakthavatchalam YD, Pragasam AK, Biswas I, Veeraraghavan B. Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanisms: an update. J Glob Antimicrob Resist. 2018.

    Article  PubMed  Google Scholar 

  15. 15.

    García-Meniño I, Díaz-Jiménez D, García V, et al. Genomic characterization of prevalent mcr-1, mcr-4, and mcr-5 Escherichia coli within Swine Enteric Colibacillosis in Spain. Front Microbiol. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Koochakzadeh A, Badouei MA. Evaluation of five polymerase chain reaction (PCR) assays for diagnosis of the Shiga Toxin 2f-producing Escherichia coli. Jpn J Infect Dis. 2016;69(6):539–41.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Markey B, Leonard F, Archambault M, Cullinane A, Maguire D. Clinical Veterinary Microbiology. Second. Edinburgh, London, New York, Oxford, Philadelphia, St Louis, Sydney, Toronto: MOSBY ELSEVIER; 2013.

  18. 18.

    Askari Badouei M, Jajarmi M, Mirsalehian A. Virulence profiling and genetic relatedness of Shiga toxin-producing Escherichia coli isolated from humans and ruminants. Comp Immunol Microbiol Infect Dis. 2015.

    Article  PubMed  Google Scholar 

  19. 19.

    Xavier BB, Lammens C, Ruhal R, et al. Identification of a novel plasmid-mediated colistinresistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Eurosurveillance. 2016.

    Article  PubMed  Google Scholar 

  20. 20.

    Maamar E, Alonso CA, Hamzaoui Z, et al. Emergence of plasmid-mediated colistin-resistance in CMY-2-producing Escherichia coli of lineage ST2197 in a Tunisian poultry farm. Int J Food Microbiol. 2018.

    Article  PubMed  Google Scholar 

  21. 21.

    Perrin-Guyomard A, Bruneau M, Houée P, et al. Prevalence of mcr-1 in commensal Escherichia coli from French livestock, 2007 to 2014. Eurosurveillance. 2016.

    Article  PubMed  Google Scholar 

  22. 22.

    Veldman K, van Essen-Zandbergen A, Rapallini M, et al. Location of colistin resistance gene mcr-1 in Enterobacteriaceae from livestock and meat. J Antimicrob Chemother. 2016.

    Article  PubMed  Google Scholar 

  23. 23.

    Hasman H, Hammerum AM, Hansen F, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, denmark 2015. Eurosurveillance. 2015.

    Article  PubMed  Google Scholar 

  24. 24.

    Barbieri NL, Nielsen DW, Wannemuehler Y, et al. mcr-1 identified in avian pathogenic Escherichia coli (APEC). PLoS ONE. 2017.

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Pishnian Z, Haeili M, Feizi A. Prevalence and molecular determinants of colistin resistance among commensal Enterobacteriaceae isolated from poultry in northwest of Iran. Gut Pathog. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Moosavian M, Emam N. The first report of emerging mobilized colistin-resistance (mcr) genes and ERIC-PCR typing in Escherichia coli and Klebsiella pneumoniae clinical isolates in southwest Iran. Infect Drug Resist. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Aghapour Z, Hasani A, Aghazadeh M, et al. Genes involved in colistin resistance of gram-negative isolates in the northwest of Iran. Gene Reports. 2019.

    Article  Google Scholar 

  28. 28.

    Liu Y, Liu JH. Monitoring colistin resistance in food animals, an urgent threat. Expert Rev Anti Infect Ther. 2018.

    Article  PubMed  Google Scholar 

  29. 29.

    Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Eurosurveillance. 2016;21(9). doi:

  30. 30.

    Irrgang A, Roschanski N, Tenhagen BA, et al. Prevalence of mcr-1 in E. coli from livestock and food in Germany, 2010–2015. PLoS One. 2016. doi:

  31. 31.

    Monte DF, Mem A, Fernandes MR, et al. Chicken meat as a reservoir of colistin-resistant Escherichia coli strains carrying mcr-1 genes in South America. Antimicrob Agents Chemother. 2017.

    Article  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Khalifa HO, Ahmed AM, Oreiby AF, Eid AM, Shimamoto T, Shimamoto T. Characterisation of the plasmid-mediated colistin resistance gene mcr-1 in Escherichia coli isolated from animals in Egypt. Int J Antimicrob Agents. 2016.

    Article  PubMed  Google Scholar 

  33. 33.

    Zhang X, Zhang B, Guo Y, et al. Colistin resistance prevalence in Escherichia coli from domestic animals in intensive breeding farms of Jiangsu Province. Int J Food Microbiol. 2019.

    Article  PubMed  Google Scholar 

  34. 34.

    Zając M, Sztromwasser P, Bortolaia V, et al. Occurrence and characterization of mcr-1-positive Escherichia coli isolated from food-producing animals in Poland, 2011–2016. Front Microbiol. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Maciuca IE, Cummins ML, Cozma AP, et al. Genetic features of mcr-1 mediated colistin resistance in CMY-2-producing Escherichia coli from Romanian poultry. Front Microbiol. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  36. 36.

    Kieffer N, Aires-de-Sousa M, Nordmann P, Poirel L. High rate of mcr-1–producing Escherichia coli and Klebsiella pneumoniae among pigs, Portugal. Emerg Infect Dis. 2017.

    Article  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Yamamoto Y, Calvopina M, Izurieta R, et al. Colistin-resistant Escherichia coli with mcr genes in the livestock of rural small-scale farms in Ecuador. BMC Res Notes. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Zhang J, Chen L, Wang J, et al. Molecular detection of colistin resistance genes (mcr-1, mcr-2 and mcr-3) in nasal/oropharyngeal and anal/cloacal swabs from pigs and poultry. Sci Rep. 2018.

    Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Singer RS. Antibiotic resistance-The interplay between antibiotic use in animals and human beings. Lancet Infect Dis. 2003.

    Article  PubMed  Google Scholar 

  40. 40.

    Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev. 2011.

    Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Hunter PA, Dawson S, French GL, et al. Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother. 2010.

    Article  PubMed  Google Scholar 

Download references


The authors would like to express their gratitude to Dr. Adriana Cabal (VISAVET health surveillance center, Spain) who kindly provided the positive control. We also would like to thank Mohammad Sadra Samiei and Ali Ziaei Kia for some laboratory assistance.


The authors received no specific funding for this research.

Author information




MAB conceived and designed the study. HV and HZ collected samples and performed the laboratory experiments of the study. MAB, KK, HV, HZ, KI and SA reviewed and analyzed the data. KI and SA wrote the first manuscript draft. Each author agrees to be accountable for all aspects of this work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mahdi Askari Badouei.

Ethics declarations

Ethics approval and consent to participate

The study was conducted according to research and ethics guidelines and approval of local institutions (Ferdowsi University of Mashhad). The samples of companion animals were obtained upon the owner’s consent. The owner consent was not required for commercial animals.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ilbeigi, K., Askari Badouei, M., Vaezi, H. et al. Molecular survey of mcr1 and mcr2 plasmid mediated colistin resistance genes in Escherichia coli isolates of animal origin in Iran. BMC Res Notes 14, 107 (2021).

Download citation


  • Colistin resistance
  • Food-producing animals
  • mcr-1
  • mcr-2